BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 19422048)

  • 1. Genomic insights into nitrofurantoin resistance mechanisms and epidemiology in clinical Enterobacteriaceae.
    Osei Sekyere J
    Future Sci OA; 2018 Jun; 4(5):FSO293. PubMed ID: 29796297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a fast and sensitive UHPLC-DAD assay for the quantification of nitrofurantoin in plasma and urine.
    Wijma RA; Hoogtanders KEJ; Croes S; Mouton JW; Brüggemann RJM
    J Pharm Biomed Anal; 2019 Sep; 174():161-167. PubMed ID: 31170629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive determination of nitrofurantoin in human plasma and urine by high-performance liquid chromatography.
    Muth P; Metz R; Siems B; Bolten WW; Vergin H
    J Chromatogr A; 1996 Apr; 729(1-2):251-8. PubMed ID: 9004947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic assay for the metabolites of nitrofurantoin in plasma and urine.
    Hoener BA; Wolff JL
    J Chromatogr; 1980 May; 182(2):246-51. PubMed ID: 7380917
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluorescence assay of nitrofurantoin with o-aminothiophenol in plasma and urine.
    Watari N; Funaki T; Kaneniwa N
    J Pharm Sci; 1980 Jan; 69(1):106-7. PubMed ID: 7354420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of nitrofurantoin (Furadantine) and hydroxymethylnitrofurantoin (Urfadyn) in plasma and urine of man by means of high-performance liquid chromatography.
    Vree TB; Hekster YA; Baars AM; Damsma JE; van der Kleijn E; Bron J
    J Chromatogr; 1979 Jan; 162(1):110-6. PubMed ID: 762206
    [No Abstract]   [Full Text] [Related]  

  • 7. SWOT and Root Cause Analyses of Antimicrobial Resistance to Oral Antimicrobial Treatment of Cystitis.
    Tyagi P; Tyagi S; Stewart L; Glickman S
    Antibiotics (Basel); 2024 Apr; 13(4):. PubMed ID: 38667004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal transcriptomic analysis of metabolic genes in maternal organs and placenta during murine pregnancy.
    Paquette A; Baloni P; Holloman AB; Nigam S; Bammler T; Mao Q; Price ND
    Biol Reprod; 2018 Dec; 99(6):1255-1265. PubMed ID: 29939228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study.
    Zhou L; Naraharisetti SB; Wang H; Unadkat JD; Hebert MF; Mao Q
    Mol Pharmacol; 2008 Mar; 73(3):949-59. PubMed ID: 18079276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.
    Merino G; Jonker JW; Wagenaar E; van Herwaarden AE; Schinkel AH
    Mol Pharmacol; 2005 May; 67(5):1758-64. PubMed ID: 15709111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the mechanism and toxicology of nitrofurantoin: a metabolomics approach.
    Sanni O; N'Da DD; Terre'Blanche G
    Drug Chem Toxicol; 2023 Nov; ():1-10. PubMed ID: 38008969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pregnancy on nitrofurantoin disposition in mice.
    Zhang Y; Zhou L; Unadkat JD; Mao Q
    J Pharm Sci; 2009 Nov; 98(11):4306-15. PubMed ID: 19422048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse.
    Zhang Y; Wang H; Unadkat JD; Mao Q
    Drug Metab Dispos; 2007 Dec; 35(12):2154-8. PubMed ID: 17785426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (-/-) mice.
    Merino G; Perez M; Real R; Egido E; Prieto JG; Alvarez AI
    Pharm Res; 2010 Oct; 27(10):2098-105. PubMed ID: 20607366
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.